Ureaplasma/Mycoplasma-infected amniotic fluid: Pregnancy outcome in treated and nontreated patients

Teresa Grace Berg, Keri L. Philpot, Melonie S. Welsh, Warren G. Sanger, Carl Vernon Smith

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

OBJECTIVE: To determine if treatment of a positive amniotic fluid culture for mycoplasmal colonization obtained at genetic amniocentesis is associated with improved pregnancy outcome. STUDY DESIGN: A retrospective analysis of 2718 genetic amniocentesis specimens cultured for Ureaplasma/Mycoplasma was undertaken. Specimens were obtained between March 1993 and January 1997. The Irvine culture kit was used to culture all specimens. Data collected included indication for amniocentesis, gestational age at amniocentesis, karyotype, gestational age at delivery, pregnancy outcome, and any antimicrobial treatment. RESULTS: During this time period 44 patients were found to be culture-positive for Ureaplasma/Mycoplasma. Thirty-five were treated with oral erythromycin. Mid-trimester loss was 11.4% and 44.4% (p = 0.04) in the treated and untreated groups, respectively. Preterm delivery was similar in the two groups, 19.4% and 20% (p = NS). CONCLUSION: Treatment of an amniotic mycoplasmal colonization with erythromycin was associated with fewer mid-trimester losses after genetic amniocentesis. Preterm delivery rates between the two groups were similar, which may indicate recolonization.

Original languageEnglish (US)
Pages (from-to)275-277
Number of pages3
JournalJournal of Perinatology
Volume19
Issue number4
DOIs
StatePublished - Jan 1 1999

Fingerprint

Ureaplasma
Amniocentesis
Mycoplasma
Amniotic Fluid
Pregnancy Outcome
Erythromycin
Gestational Age
Karyotype
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Ureaplasma/Mycoplasma-infected amniotic fluid : Pregnancy outcome in treated and nontreated patients. / Berg, Teresa Grace; Philpot, Keri L.; Welsh, Melonie S.; Sanger, Warren G.; Smith, Carl Vernon.

In: Journal of Perinatology, Vol. 19, No. 4, 01.01.1999, p. 275-277.

Research output: Contribution to journalArticle

@article{062dd7475aa845b3bb846e47d8a17973,
title = "Ureaplasma/Mycoplasma-infected amniotic fluid: Pregnancy outcome in treated and nontreated patients",
abstract = "OBJECTIVE: To determine if treatment of a positive amniotic fluid culture for mycoplasmal colonization obtained at genetic amniocentesis is associated with improved pregnancy outcome. STUDY DESIGN: A retrospective analysis of 2718 genetic amniocentesis specimens cultured for Ureaplasma/Mycoplasma was undertaken. Specimens were obtained between March 1993 and January 1997. The Irvine culture kit was used to culture all specimens. Data collected included indication for amniocentesis, gestational age at amniocentesis, karyotype, gestational age at delivery, pregnancy outcome, and any antimicrobial treatment. RESULTS: During this time period 44 patients were found to be culture-positive for Ureaplasma/Mycoplasma. Thirty-five were treated with oral erythromycin. Mid-trimester loss was 11.4{\%} and 44.4{\%} (p = 0.04) in the treated and untreated groups, respectively. Preterm delivery was similar in the two groups, 19.4{\%} and 20{\%} (p = NS). CONCLUSION: Treatment of an amniotic mycoplasmal colonization with erythromycin was associated with fewer mid-trimester losses after genetic amniocentesis. Preterm delivery rates between the two groups were similar, which may indicate recolonization.",
author = "Berg, {Teresa Grace} and Philpot, {Keri L.} and Welsh, {Melonie S.} and Sanger, {Warren G.} and Smith, {Carl Vernon}",
year = "1999",
month = "1",
day = "1",
doi = "10.1038/sj.jp.7200185",
language = "English (US)",
volume = "19",
pages = "275--277",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Ureaplasma/Mycoplasma-infected amniotic fluid

T2 - Pregnancy outcome in treated and nontreated patients

AU - Berg, Teresa Grace

AU - Philpot, Keri L.

AU - Welsh, Melonie S.

AU - Sanger, Warren G.

AU - Smith, Carl Vernon

PY - 1999/1/1

Y1 - 1999/1/1

N2 - OBJECTIVE: To determine if treatment of a positive amniotic fluid culture for mycoplasmal colonization obtained at genetic amniocentesis is associated with improved pregnancy outcome. STUDY DESIGN: A retrospective analysis of 2718 genetic amniocentesis specimens cultured for Ureaplasma/Mycoplasma was undertaken. Specimens were obtained between March 1993 and January 1997. The Irvine culture kit was used to culture all specimens. Data collected included indication for amniocentesis, gestational age at amniocentesis, karyotype, gestational age at delivery, pregnancy outcome, and any antimicrobial treatment. RESULTS: During this time period 44 patients were found to be culture-positive for Ureaplasma/Mycoplasma. Thirty-five were treated with oral erythromycin. Mid-trimester loss was 11.4% and 44.4% (p = 0.04) in the treated and untreated groups, respectively. Preterm delivery was similar in the two groups, 19.4% and 20% (p = NS). CONCLUSION: Treatment of an amniotic mycoplasmal colonization with erythromycin was associated with fewer mid-trimester losses after genetic amniocentesis. Preterm delivery rates between the two groups were similar, which may indicate recolonization.

AB - OBJECTIVE: To determine if treatment of a positive amniotic fluid culture for mycoplasmal colonization obtained at genetic amniocentesis is associated with improved pregnancy outcome. STUDY DESIGN: A retrospective analysis of 2718 genetic amniocentesis specimens cultured for Ureaplasma/Mycoplasma was undertaken. Specimens were obtained between March 1993 and January 1997. The Irvine culture kit was used to culture all specimens. Data collected included indication for amniocentesis, gestational age at amniocentesis, karyotype, gestational age at delivery, pregnancy outcome, and any antimicrobial treatment. RESULTS: During this time period 44 patients were found to be culture-positive for Ureaplasma/Mycoplasma. Thirty-five were treated with oral erythromycin. Mid-trimester loss was 11.4% and 44.4% (p = 0.04) in the treated and untreated groups, respectively. Preterm delivery was similar in the two groups, 19.4% and 20% (p = NS). CONCLUSION: Treatment of an amniotic mycoplasmal colonization with erythromycin was associated with fewer mid-trimester losses after genetic amniocentesis. Preterm delivery rates between the two groups were similar, which may indicate recolonization.

UR - http://www.scopus.com/inward/record.url?scp=0033138478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033138478&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7200185

DO - 10.1038/sj.jp.7200185

M3 - Article

C2 - 10685238

AN - SCOPUS:0033138478

VL - 19

SP - 275

EP - 277

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 4

ER -